397
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Seroprevalence and Associated Risk Factors of Brucellosis Among Human Population in Duhok City, Iraq

ORCID Icon
Pages 2805-2811 | Received 18 Feb 2023, Accepted 29 Apr 2023, Published online: 08 May 2023

References

  • Głowack P, Żakowska D, Naylor K, et al. Brucella – virulence factors, pathogenesis and treatment. Pol J Microbiol. 2018;67:151–161. doi:10.21307/pjm-2018-029
  • Seleem MN, Boyle SM, Sriranganathan N. Brucellosis: a re-emerging zoonosis. Vet Microbiol. 2010;140:392–398. doi:10.1016/j.vetmic.2009.06.021
  • Xavier MN, Costa EA, Paixão TA, et al. The genus Brucella and clinical manifestations of brucellosis. Ciênc Rural. 2009;39:2252–2260. doi:10.1590/S0103-84782009005000167
  • Bukhari EE. Pediatric brucellosis. An update review for the new millennium. Saudi Med J. 2018;9:336–341. doi:10.15537/smj.2018.4.21896
  • Godfroid J, Al Dahouk S, Pappas G, et al. One Health” surveillance and control of brucellosis in developing countries: moving away from improvisation. Comp Immunol Microbiol Infect Dis. 2013;36:241–248. doi:10.1016/j.cimid.2012.09.001
  • Ay N, Kaya S, Anil M, et al. Pulmonary involvement in brucellosis, a rare complication of renal transplant: case report and brief review. Exp Clin Transplant. 2018;16:757–760. doi:10.6002/ect.2015.0324
  • Buzgan T, Karahocagil MK, Irmak H, et al. Clinical manifestations and complications in 1028 cases of brucellosis: a retrospective evaluation and review of the literature. Int J Infect Dis. 2010;14:e469–e478. doi:10.1016/j.ijid.2009.06.031
  • Herrick JA, Lederman RJ, Sullivan B, et al. Brucella arteritis: clinical manifestations, treatment, and prognosis. Lancet Infect Dis. 2014;14:520–526. doi:10.1016/S1473-3099(13)70270-6
  • Dean AS, Crump L, Greter H, et al. Global burden of human brucellosis: a systematic review of disease frequency. PLoS Negl Trop Dis. 2012;6:e1865. doi:10.1371/journal.pntd.0001865
  • Rubach MP, Halliday JE, Cleaveland S, et al. Brucellosis in low-income and middle-income countries. Curr Opin Infect Dis. 2013;26:404–412. doi:10.1097/QCO.0b013e3283638104
  • Adel M. Survey on therapeutic protocols of Human brucellosis prescribed by urban and rural physicians and persistence risk factors in the Governorate of Biskra. Algeria J Pharm Chem Biol Sci. 2018;5(4):437–448.
  • Chomel BB, Debess EE, Mangiamele DM, et al. Changing trends in the epidemiology of human brucellosis in California from 1973 To 1992: a shift toward foodborne transmission. J Infect Dis. 1994;170:1216–1223. doi:10.1093/infdis/170.5.1216
  • Schelling E, Diguimbaye C, Daoud S, et al. Brucellosis and Q-fever seroprevalences of nomadic pastoralists and their livestock in Chad. Prev Vet Med. 2003;61:279–293. doi:10.1016/j.prevetmed.2003.08.004
  • Almashhadany DA. Prevalence of brucellosis in human and camels in Thamar Province/Yemen. J Saudi Soc Agric Sci. 2014;13:132–137.
  • Di Bonaventura G, Angeletti S, Ianni A, et al. Microbiological laboratory diagnosis of human brucellosis: an overview. Pathogens. 2021:101623. doi:10.3390/pathogens10121623
  • Ruiz-Mesa JD, Sánchez-Gonzalez J, Reguera JM, et al. Rose Bengal test: diagnostic yield and use for the rapid diagnosis of human brucellosis in emergency departments in endemic areas. Clin Microbiol Infect. 2005;11:221–225. doi:10.1111/j.1469-0691.2004.01063.x
  • Mantur BG, Amarnath SK, Shinde RS. Review of clinical and laboratory features of human brucellosis. Indian J Med Microbiol. 2007;25:188–202. doi:10.4103/0255-0857.34758
  • Assafi MS, Allu MA, Abdulrahman IS, et al. The seroprevalence of human brucellosis in different age groups patients and other associated risk factors in Duhok, Iraq. Rev Innovaciencia. 2019;7:1–7. doi:10.15649/2346075X.479
  • Rasul D, Mansoor I, Hussein K. Seroprevalence of human brucellosis in Erbil city. Zanco J Med Sci. 2012;16:220–226. doi:10.15218/zjms.2012.0038
  • Keramat F, Karami M, Alikhani MY, et al. Cohort profile: famenin brucellosis cohort study. J Res Health Sci. 2019;19:e00453.
  • Alkahtani AM, Assiry MM, Chandramoorthy HC, et al. Sero-prevalence and risk factors of brucellosis among suspected febrile patients attending a referral hospital in southern Saudi Arabia (2014–2018). BMC Infect Dis. 2020;20:1–8. doi:10.1186/s12879-020-4763-z
  • Aypak C, Altunsoy A, Çelik AK. Epidemiological and clinical aspects of human brucellosis in eastern Anatolia. J Nippon Med Sch. 2012;79:343–348. doi:10.1272/jnms.79.343
  • Gafirita J, Kiiza G, Murekatete A, et al. Seroprevalence of Brucellosis among patients attending a district hospital in Rwanda. Am J Trop Med Hyg. 2017;97:831–835. doi:10.4269/ajtmh.16-0632
  • Bansal Y, Aggarwal A, Gadepalli R, et al. Seroprevalence of brucellosis in Western Rajasthan: a study from a tertiary care centre. Indian J Med Microbiol. 2019;37:426–429. doi:10.4103/ijmm.IJMM_19_358
  • Kiambi SG, Fèvre EM, Omolo J, et al. Risk factors for acute human brucellosis in Ijara, northeastern Kenya. PLoS Negl Trop Dis. 2020;14:e0008108. doi:10.1371/journal.pntd.0008108
  • Al-Sekait MA. Epidemiology of brucellosis in al Medina region, Saudi Arabia. J Family Community Med. 2000;7:47.
  • Niaz S, Raqeeb A, Khan A, et al. Status of human brucellosis in district Malakand, Khyber Pakhtunkhwa, Pakistan. J Infect Public Health. 2021;14:423–427. doi:10.1016/j.jiph.2019.12.013
  • Aloufi AD, Memish ZA, Assiri AM, et al. Trends of reported human cases of brucellosis, Kingdom of Saudi Arabia, 2004–2012. J Epidemiol Glob Health. 2016;6:11–18. doi:10.1016/j.jegh.2015.09.001
  • Malik S, Sarwar I, Rauf A, et al. Seroprevalence of brucellosis among patients presenting with non-specific symptoms at Ayub Teaching Hospital Abbottabad. J Ayub Med Coll Abbottabad. 2018;30:566–570.
  • Ebrahimpour S, Youssefi MR, Karimi N, et al. The prevalence of human Brucellosis in Mazandaran province, Iran. African J Microbiol Res. 2012;6:4090–4094. doi:10.5897/AJMR11.1076
  • Dieckhaus KD, Kyebambe PS. Human brucellosis in rural Uganda: clinical manifestations, diagnosis, and comorbidities at Kabale Regional Referral Hospital, Kabale, Uganda. Open Forum Infect Dis. 2017;4:1–6. doi:10.1093/ofid/ofx237
  • Perez A, Berhe M. Brucella, a bacterium with multiple ways of causing infection. Baylor Univ Med Cent Proc. 2020;34:99–101. doi:10.1080/08998280.2020.1805674
  • González-Espinoza G, Arce-Gorvel V, Mémet S, et al. Brucella: reservoirs and niches in animals and humans. Pathogens. 2021;10:186. doi:10.3390/pathogens10020186
  • Refai M. Incidence and control of brucellosis in the Near East region. Vet Microbiol. 2002;90:81–110. doi:10.1016/s0378-1135(02)00248-1
  • Hashemifar I, Yadegar A, Jazi FM, Amirmozafari N. Molecular prevalence of putative virulence-associated genes in Brucella melitensis and Brucella abortus isolates from human and livestock specimens in Iran. Microb Pathog. 2017;105:334–339. doi:10.1016/j.micpath.2017.03.007
  • Elfaki MG, Uz-Zaman T, Al-Hokail AA, et al. Detection of Brucella DNA in sera from patients with brucellosis by polymerase chain reaction. Diagn Microbiol Infect Dis. 2005;53:1–7. doi:10.1016/j.diagmicrobio.2005.03.011
  • Dal T, Kara SS, Cikman A. Comparison of multiplex real-time polymerase chain reaction with serological tests and culture for diagnosing human brucellosis. J Infect Public Health. 2019;12:337–342. doi:10.1016/j.jiph.2018.11.008
  • Khurana SK, Sehrawat A, Tiwari R, et al. Bovine brucellosis – a comprehensive review. Vet Q. 2021;41:61–88. doi:10.1080/01652176.2020.1868616
  • Raies Ul Islam M, Pratap GM, Kaur SP, et al. Comparative evaluation of indirect enzyme linked immunosorbent assay, Rose Bengal plate test, microagglutination test, and polymerase chain reaction for diagnosis of brucellosis in buffaloes. Turk J Vet Anim Sci. 2013;37:306–310. doi:10.3906/vet-1201-39
  • Ekiri AB, Kilonzo C, Bird BH, et al. Utility of the Rose Bengal Test as a point-of-care test for human brucellosis in endemic African settings: a systematic review. J Trop Med. 2020:6586182. doi:10.1155/2020/6586182